Table 5.
Odd Ratio for Lp-PLA2activity highest quartile
| |
Lp-PLA2 |
|
|
|---|---|---|---|
| <15.9 | ≥15.9 | P* | |
|
TC, mg/dL |
1 Ref |
1.012 |
0.004 |
|
LDL-C, mg/dL |
1 Ref |
1.012 |
0.003 |
|
HDL-C, mg/dL |
1 Ref |
0.983 |
0.162 |
|
TG, mg/dL |
1 Ref |
1.004 |
0.178 |
|
HOMA-IR |
1 Ref |
1.127 |
0.032 |
|
HDL size, nm |
1 Ref |
0.930 |
0.245 |
|
LDL(−), mg/mL |
1 Ref |
1.000 |
0.757 |
|
Anti LDL(−), mg/mL |
1 Ref |
0.878 |
0.020 |
|
Apo AI mg/dL |
1 Ref |
0.993 |
0.374 |
|
Apo B mg/dL |
1 Ref |
1.042 |
0.000 |
|
Apo B/Apo AI |
1 Ref |
73.5 |
0.000 |
|
LDL-C/ApoB |
1 Ref |
1.265 |
0.443 |
|
HDL-C/ApoAI |
1 Ref |
0.123 |
0.168 |
|
BMI, kg/m2 |
1 Ref |
1.022 |
0.340 |
|
WC, cm |
1 Ref |
1.014 |
0.126 |
| Fat mass,% | 1 Ref | 1.015 | 0.379 |
HW, healthy weight; OV, overweight; OB, obese; BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol, TG, triglycerides; LDL, low density lipoprotein; HDL, high density lipoprotein.
*Significant level (P < 0.05).